P04275 (VWF_HUMAN) Homo sapiens (Human)
von Willebrand factor UniProtKBInterProSTRINGInteractive Modelling
2813 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
48 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM structure of VWF D'D3 dimer complexed with D1D2 at 4.3 angstron resolution (7 units) |
Heteromer | 42×NAG; 56×CA; | ||||
| Assess | ||||||
| Cryo-EM structure of VWF D'D3 dimer complexed with D1D2 at 4.3 angstron resolution (VWF tube) |
Heteromer | 42×NAG; 56×CA; | ||||
| Assess | ||||||
| VWF D'D3 dimer complexed with D1D2 at 4.39 angstron resolution(VWF tube) |
Heteromer | 42×NAG; 56×CA; | ||||
| Assess | ||||||
| Cryo-EM structure of VWF D'D3 dimer complexed with D1D2 at 2.85 angstron resolution (1 unit) |
Heteromer | 6×CA; 10×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of VWF D'D3 dimer complexed with D1D2 at 3.27 angstron resolution (2 units) |
Heteromer | 20×NAG; 16×CA; | ||||
| Assess | ||||||
| Cryo-EM structure of VWF D'D3 dimer (R1136M/E1143M mutant) complexed with D1D2 at 3.29 angstron res… |
Heteromer | 16×CA; 20×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of VWF D'D3 dimer (2M mutant) complexed with D1D2 at 3.29 angstron resolution (2 … |
Heteromer | 16×CA; 20×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of VWF D'D3 dimer (wild type) complexed with D1D2 at 3.4 angstron resolution (1 u… |
Heteromer | 6×CA; 8×NAG; | ||||
| Assess | ||||||
| rFVIIIFc-VWF-XTEN (BIVV001) |
Heteromer P00451; | 1×NAG; 3×NAG; 2×CA; 1×ZN; 1×CU; | ||||
| Assess | ||||||
| The ternary von Willebrand Factor A1-glycoprotein Ibalpha-botrocetin complex |
Heteromer P07359; P22029; P22030; | |||||
| Assess | ||||||
| High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based m… |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of High-Affinity von Willebrand Factor A1 domain with R1306Q and I1309V Mutations… |
Heteromer P07359; | 1×CAC; 1×ACT; 1×CA; 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of von Willebrand Factor A1 domain complexed with snake venom bitiscetin |
Heteromer Q7LZK5; Q7LZK8; | |||||
| Assess | ||||||
| The von Willebrand Factor mutant (I546V) A1 domain-botrocetin Complex |
Heteromer P22029; P22030; | |||||
| Assess | ||||||
| Crystal Structure of High-Affinity von Willebrand Factor A1 domain with Disulfide Mutation in Compl… |
Heteromer P07359; | 2×SO4; 1×MES; | ||||
| Assess | ||||||
| Crystal structure of the complex of Glycoprotein Ib alpha and the von Willebrand Factor A1 Domain |
Heteromer P07359; | |||||
| Assess | ||||||
| Crystal Structure of the Complex of the Wild-type Von Willebrand Factor A1 domain and Glycoprotein … |
Heteromer P07359; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKIN… |
Heteromer P01868; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUN… |
Heteromer P01837; P01868; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 … |
Heteromer P01863; | 1×NAG; 1×NAG; 1×CAC; | ||||
| Assess | ||||||
| Crystal Structure and Paratope Determination of 82D6A3, an Antithrombotic Antibody Directed Against… |
Heteromer P84751; | 1×ACY; 2×SO4; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the von Willebrand factor A3 domain in complex with a collagen III derived tri… |
Heteromer | |||||
| Assess | ||||||
| VWF Tubules of D1D2D'D3 domains | homo-36-mer | 36×NAG; 144×NAG; 108×CA; | ||||
| Assess | ||||||
| VWF tubule derived from monomeric D1-A1 | homo-16-mer | 48×CA; 80×NAG; | ||||
| Assess | ||||||
| VWF tubule derived from dimeric D1-A1 | homo-16-mer | 48×CA; 80×NAG; | ||||
| Assess | ||||||
| VWF Tubules of D1D2 and D'D3A1 domains | homo-4-mer | 2×NAG; 8×NAG; 6×CA; | ||||
| Assess | ||||||
| VWF Tubules of D1D2D'D3 domains | homo-4-mer | 3×NAG; 1×NAG; 16×NAG; 12×CA; | ||||
| Assess | ||||||
| Crystal structure of human von Willebrand factor CTCK domain | homo-2-mer | 2×NAG; 2×ZN; 10×SO4; | ||||
| Assess | ||||||
| Crystal structure of monomeric von Willebrand Factor D`D3 assembly | monomer | 3×NAG; 2×CA; 1×PEG; | ||||
| Assess | ||||||
| G1324S mutation in von Willebrand Factor A1 domain | monomer | 1×EDO; 1×CL; | ||||
| Assess | ||||||
| A1 DOMAIN OF VON WILLEBRAND FACTOR | monomer | 1×CD; | ||||
| Assess | ||||||
| The von Willebrand Factor mutant (I546V) A1 domain | monomer | |||||
| Assess | ||||||
| Crystal Structure of High-Affinity von Willebrand Factor A1 domain with Disulfide Mutation | monomer | 1×ACT; 2×PEG; 1×CA; | ||||
| Assess | ||||||
| Crystal Structure of Von Willebrand Factor (VWF) A1 Domain in Complex with DNA Aptamer ARC1172, an … | monomer | |||||
| Assess | ||||||
| Crystal Structure of Von Willebrand Factor (VWF) A1 Domain in Complex with DNA Aptamer ARC1172, an … | monomer | |||||
| Assess | ||||||
| von Willebrand factor (VWF) A1 domain with BT-100 aptamer RNA | monomer | 1×GOL; | ||||
| Assess | ||||||
| A3 DOMAIN OF VON WILLEBRAND FACTOR | monomer | |||||
| Assess | ||||||
| Crystal structure of the D1596A/N1602A double mutant of an engineered VWF A2 domain (N1493C and C16… | monomer | 1×NA; | ||||
| Assess | ||||||
| HUMAN VON WILLEBRAND FACTOR A3 DOMAIN | monomer | |||||
| Assess | ||||||
| Crystal structure of an engineered VWF A2 domain (N1493C and C1670S) | monomer | 1×SO4; 1×CA; | ||||
| Assess | ||||||
| Crystal structure of the D1596A mutant of an engineered VWF A2 domain (N1493C and C1670S) | monomer | 1×NA; | ||||
| Assess | ||||||
| Crystal structure of the N1602A mutant of an engineered VWF A2 domain (N1493C and C1670S) | monomer | 1×NA; | ||||
| Assess | ||||||
| Von Willebrand Factor A2 domain with calcium | monomer | 2×GOL; 1×CA; 2×NAG; | ||||
| Assess | ||||||
| Crystal structure of VWF A2 domain | monomer | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| Solution structure of the major factor VIII binding region on von Willebrand factor | monomer | |||||
| Assess | ||||||
| Solution structure of the major factor VIII binding region on von Willebrand factor | monomer | |||||
| Assess | ||||||
| Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor | monomer | |||||
| Assess | ||||||
| NMR solution structure of the C6 domain of von Willebrand Factor | monomer | |||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8d3d.1.A | homo-16-mer | 0.70 | 48×CA; 16×NAG; | 99.66 | ||
| Assess | ||||||
| 7pmv.1.A | homo-4-mer | 0.67 | 4×NAG; 12×CA; | 99.92 | ||
| Assess | ||||||
| 7qcu.1.A | homo-2-mer | 0.54 | 29.02 | |||
| Assess | ||||||
3 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4nt5.1.A | monomer | 0.75 | 100.00 | ||
| Assess | ||||||
| Isoform 2 | 8d3d.1.A | monomer | 0.74 | 1×CA; | 82.86 | |
| Assess | ||||||
| Isoform 2 | 8d3c.1.A | monomer | 0.58 | 25.18 | ||
| Assess | ||||||